Effects of gender and estradiol treatment on focal brain ischemia

Brain Research

Volumn 784, Issue 1-2, 1998, Pages 321-324

  Zhang, Yu Qi ^a   Shi, Jiong ^a   Rajakumar, Gopal ^a   Day, Arthur L ^a   Simpkins, James W ^a  

^a Department of Pharmacotherapy and Translational Research   (United States)

Author keywords

17 Estradiol; Estrogen; Ischemia; Middle cerebral artery occlusion; Ovariectomy; Sex dependent mortality

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DRUG VEHICLE; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; GENDER; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REPERFUSION; SEX DIFFERENCE;

ANIMALS; BRAIN; BRAIN ISCHEMIA; ESTRADIOL; FEMALE; MALE; OLFACTORY BULB; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

EID: 0032536475     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00502-7     Document Type: Article

References (29)

1. Bar J., Temper R., Fuchs J., Pardo Y., Goldberger S., Ovadia J. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet. Gynecol. 81:1993;261-264.
2. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;1304-1308.
3. Behl C., Widmann M., Trapp T., Holsboer F. 17β-Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:1995;473-482.
4. Bishop J., Simpkins J.W. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol. Cell. Neurosci. 5:1994;303-308.
5. Bishop J., Simpkins J.W. Estradiol enhances brain glucose uptake in ovariectomized rats. Brain Res. Bull. 36(3):1995;315-320.
6. Brewster M.E., Simpkins J.W., Bodor N. Brain-targeted delivery of estrogens. Rev. Neurosci. 2:1990;241-285.
7. Brewster M.E., Simpkins J.W., Hora M.S., Stern W.C., Bodor N. The potential use of cyclodextrins in parenteral formulations. J. Parenter Sci. Technol. 43:1989;231-240.
8. Finucane F.F., Madans J.H., Bush T.L., Wolf P.H., Kleinman J.C. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch. Intern. Med. 153:1993;73-79.
9. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
10. Green P.S., Gridley K.E., Simpkins J.W. Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218:1996;165-168.
11. Hillard T.C., Whitcroft S., Ellerington M.C. The long-term risks and benefits of hormone replacement therapy. J. Clin. Pharm. Ther. 16:1991;231-245.
12. Honjo H., Tamura T., Matsumoto Y., Kawata M., Ogino Y., Tanaka K., Yamamoto T., Ueda S., Okada H. Estrogen as a growth factor to central nervous cells. Estrogen treatment promotes development of acetylcholinesterase-positive basal forebrain neurons transplanted in the anterior eye chamber. J. Steroid Biochem. Mol. Biol. 41:1992;633-635.
13. Hurn P.D., Littleton-Kearney M.T., Kirsch J.R., Dharmarajan A.M., Traystman R.J. Post-ischemic cerebral blood flow recovery in the female: effect of 17β-estradiol. J. Cereb. Blood Flow Metab. 15:1995;666-672.
14. Kelly M.A., Gorelick P.B., Mirza D. The role of drugs in the etiology of stroke. Clin. Neuropharmacol. 15:1992;249-275.
15. Lobo R.A. Cardiovascular implications of estrogen replacement therapy. Obstet. Gynecol. 75:1990;18s-25s.
16. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
17. McEwen B.S., Coirini H., Westlind-Danelsson A., Frankfurt M., Schumacher M., Woolley C. Steroid hormones as mediators of neural plasticity. J. Steroid Biochem. Mol. Biol. 39:1991;223-232.
18. Mortel K.F., Meyer J.S. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J. Neuropsychiatry Clin. Neurosci. 7:1995;334-337.
19. Nagasawa H., Kyuya K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke. 20:1989;1037-1043.
20. Paganini-Hill A. Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38:1995;223-242.
21. Rahimy M.H., Bodor N., Simpkins J.W. A rapid, sensitive method for the simultaneous quantitation of estradiol and estradiol conjugates in a variety of tissues: assay development and evaluation of the distribution of a brain-enhanced estradiol-chemical delivery system. J. Steroid Biochem. 33:1989;179-187.
22. Singer C.A., Rogers K.L., Strickland T.M., Dorsa D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212:1996;13-16.
23. Simpkins J.W., Singh M., Bishop J. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol. Aging. 15:1994;s195-s197.
24. Stampfer M.J., Colditz F.A., Willett W.C., Manson J.E., Rosner B., Speizer F.E., Hennekens C.H. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N. Engl. J. Med. 325:1991;756-762.
25. Toran-Allerand C.D., Miranda R.C., Bentham W.D., Sohrabji F., Brown T.J., Hochberg R.B., MacLusky N.J. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. 89:1992;4668-4672.
26. Ylikorkala O., Hirvonen E., Saure A., Viinikka L. Urinary excretion of prostacyelin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy. Prostaglandins. 39:1990;33-37.
27. Chan P.H. Oxygen radicals in focal cerebral ischemia. Brain Pathol. 4:1994;59-65.
28. Shi J., Simpkins J.W. 17 β-Estradiol modulation of glucose transporter 1 (GLUT 1) expression in blood-brain barrier. Am. J. Physiol. 272:1997;E1016-E1022.
29. J. Shi, Y.Q. Zhang, J.W. Simpkins, Effects of 17 β-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats. Exp. Brain Res. 1997, in press.